In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma

@inproceedings{Jaworski2015InVA,
  title={In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma},
  author={Sławomir Jaworski and Ewa Sawosz and Marta Kutwin and Mateusz Wierzbicki and Mateusz Hinzmann and Marta Grodzik and Anna Winnicka and Ludwika Lipińska and Karolina Włodyga and Andr{\'e} Chwalibog},
  booktitle={International journal of nanomedicine},
  year={2015}
}
Graphene and its related counterparts are considered the future of advanced nanomaterials owing to their exemplary properties. However, information about their toxicity and biocompatibility is limited. The objective of this study is to evaluate the toxicity of graphene oxide (GO) and reduced graphene oxide (rGO) platelets, using U87 and U118 glioma cell lines for an in vitro model and U87 tumors cultured on chicken embryo chorioallantoic membrane for an in vivo model. The in vitro investigation… CONTINUE READING
Highly Cited
This paper has 17 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

PEGylated nanographene oxide for delivery of water-insoluble cancer drugs.

Journal of the American Chemical Society • 2008
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…